once they get above 50%... and control of the board - Iberdola has said they intend to exert pressure to delist the company from ASX... much less scrutiny and less focus of "benefit for all shareholders" - if TCI went with their vote (from their remaining 13% shareholding you would assume maintaining board role) we would not have a choice in the matter... outvoiced.
Agree that we could have a real stalemate here if UAC hold onto their position ... will require a fair chunk of the free standing shares to get to 50%... Vinva has a 5% stake still... and the board and their relevant associated holdings + performance rights which are expected to be issued will make another few percent - but I still feel I will be surprised if either party races towards 50%... let alone gets above 50%.
UAC have gone unconditional though - so it could just try and increase its stake to get a seat on the board and work forward with IFN... whereas Iberdola is majority holder or not at all. I still prefer option number 3.
Such a great company and we have seen / discussed many of the opportunities they have available to them here on the forum... just wish they had of come to us for a CR to get balance sheet in order for growth (increase available leverage) before having approached Iberdola and appearing (in hindsight) as having a pipeline, with no scope to develop due to capital restraints. Would have participated 200%.
- Forums
- ASX - By Stock
- IFN
- Ann: Second Supplementary Target's Statement to UAC Offer
IFN
infragreen group limited
Add to My Watchlist
0.00%
!
$1.15

Ann: Second Supplementary Target's Statement to UAC Offer, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $155.4M |
Open | High | Low | Value | Volume |
$1.19 | $1.20 | $1.12 | $637.6K | 559.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14454 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 14868 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14454 | 1.140 |
1 | 28425 | 1.120 |
3 | 102523 | 1.100 |
1 | 10000 | 1.080 |
1 | 30000 | 1.070 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 14868 | 1 |
1.210 | 21405 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IFN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online